Ledger.Open graph →

SEC Form D · Amendment · filed December 30, 2016

XERIS PHARMACEUTICALS INC

Offering

$50.0M

Sold

$45.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

AUSTIN, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Navneet Puri · Austin, TXDirector Cary Mcnair · Austin, TXDirector Robert Faulker · Austin, TXDirector Douglas Baum · Austin, TXExec · Director Steven Prestrelski · Austin, TXExec Janan Paskaran · Calgary, Alberta, CanadaDirector Ariel Garten · Toronto, Ontario, CanadaDirector Jerry Kroll · VANCOUVER, British Columbia, CanadaDirector Malcolm C. Persen · South Orange, NJExec Thomas Wenz · Calgary, Alberta, CanadaExec · Director Poul Strange · Austin, TXExec Jonathan Rigby · Austin, TXDirector Thomas English · Calgary, Alberta, CanadaDirector William Mason · San Francisco, CADirector Ed Theobald · VANCOUVER, British Columbia, CanadaDirector Sid Paquette · Toronto, Ontario, CanadaExec · Director Bradley Mascho · Columbus, OHExec Poul Strange · Austin, TXExec Jonathan Rigby · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗